Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00970190 · ClinicalTrials.gov registry record
Olfactory Dysfunction of Rhinosinusitis - Cyclic Adenosine Monophosphate (cAMP)/Calcium Signaling Study
A clinical trial, sponsored by Greg Davis.
- Completed
- Registry status
- 99
- Enrollment target
NCT00970190 is a clinical trial that has completed, run by Greg Davis. The registered enrollment target is 99 participants.
The verdict
NCT00970190 has completed, sponsored by Greg Davis.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The study examines the biochemistry underlying human olfaction in both normal and diseased states. The study aims are: 1. to determine the levels of cAMP in olfactory tissue from people with chronic rhinosinusitis and other nasal disorders. 2. to correlate preoperative olfactory function with cAMP levels from biopsied olfactory tissue. 3. to determine odorant and pheromone-mediated activation of cultured human olfactory sensory neurons using calcium imaging and 4. to determine odorant and pheromone-mediated activation of cultured human olfactory sensory neurons using "smell-chip" technology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00970190
The ClinicalTrials.gov registry entry for NCT00970190 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Greg Davis, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00970190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00970190 about?
NCT00970190 is a clinical study titled "Olfactory Dysfunction of Rhinosinusitis - Cyclic Adenosine Monophosphate (cAMP)/Calcium Signaling Study". The study examines the biochemistry underlying human olfaction in both normal and diseased states. The study aims are: 1. to determine the levels of cAMP in olfactory tissue from people with chronic rhinosinusitis and other nasal disorders. 2. to correlate preoperative olfactory function with cAMP ...
What is the current status of trial NCT00970190?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2009-08. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT00970190?
This trial is sponsored by Greg Davis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.